Pfizer Q1 profit up 9 percent on higher drug sales, lower costs Medical Dialogues Bureau2 May 2019 9:07 AM ISTPfizer modestly lifted its full-year profit forecast. The company also bought back $8.9 billion worth of shares in the first quarter, a jump from the...
GSK expects shingles drug sales to exceed $1.3 billion Garima2 May 2019 9:00 AM ISTFTSE-100 member GSK, whose shares were up 0.3 per cent to 1,580 pence at 1156 GMT, also said it had decided to stop the clinical development of its...
Zydus Cadila gets USFDA nod to market 2 generic drugs Medical Dialogues Bureau1 May 2019 8:05 PM ISTNew Delhi: Drug firm Zydus Cadila Tuesday said it has received the final nod from the USFDA to market generic Bosentan tablets and Trientine...
Lupin-Natco get USFDA nod to market generic hypertension drug Medical Dialogues Bureau1 May 2019 8:05 PM ISTNew Delhi: Drug firm Lupin, in alliance with Natco Pharma, has received approval from the US health regulator to market generic Bosentan tablets used...
RAID: CDSCO seizes 2350 kg drugs including Erythromycin, Vitamon D, Folic Acid worth over Rs 1.5 crores in Chennai Farhat Nasim1 May 2019 12:15 PM ISTNew Delhi: In a major crackdown, the Central Drugs Standard Control Organisation (CDSCO) has confiscated bulk drugs including Erythromycin, Megestrol...
Vaccine and blood thinner help drive Pfizer to quarterly earnings beat Medical Dialogues Bureau1 May 2019 12:07 PM ISTPfizer Inc on Tuesday reported a first-quarter profit that beat Wall Street estimates and slightly raised its 2019 earnings forecast, as the company...
USFDA declines to approve Nabriva's antibiotic Contepo for urinary tract infections Medical Dialogues Bureau1 May 2019 12:02 PM ISTThe U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic Contepo for complicated urinary tract...
Ghana becomes second country to launch vital malaria vaccine Medical Dialogues Bureau1 May 2019 10:04 AM ISTGhana on Tuesday rolled out the world's only proven malaria vaccine for infants as part of a landmark campaign against the deadly mosquito-borne...
Bayer can absorb Roundup costs of 5 billion euros, but not 20 billion - Moody's Medical Dialogues Bureau1 May 2019 9:04 AM ISTBERLIN: Bayer could absorb litigation costs of up to 5 billion euros ($5.59 billion) to settle ongoing lawsuits linked to its Monsanto weed-killer...
Glenmark launches SGLT2 Inhibitor Remogliflozin under brand names Remo, Remozen Meghna A Singhania30 April 2019 10:16 AM ISTGlenmark will commercialize Remogliflozin in India under the brand names 'Remo' and 'Remozen'.Mumbai: In a major relief to diabetics, Glenmark...
CDSCO approves Zydus, SIFI pact to launch Intraocular Lenses in India Farhat Nasim30 April 2019 10:15 AM IST"SIFI's innovative IOLs (Intraocular lenses) have been approved by the Indian Central Drugs Standards Control Organisation(CDSCO) (Directorate General...
Cipla gets USFDA nod for Ambrisentan tablets to treat pulmonary arterial hypertension Farhat Nasim30 April 2019 10:00 AM ISTCipla's Ambrisentan tablets 5 mg and 10 mg is AB-rated generic therapeutic equivalent version of Gilead Sciences Inc's Letairis.New Delhi: Drug major...
